SMLR
$58.00
Semler Scientific
$1.74
3.09%
SMLR
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  $0.15
Revenue:  $8.62 Mil
Wednesday
Nov 4
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when SMLR reports earnings?
Beat
Meet
Miss

Where is SMLR's stock price going from here?
Up
Flat
Down
Stock chart of SMLR
Analysts
Summary of analysts' recommendations for SMLR
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Semler Scientific, Inc. is a medical risk-assessment company. The Company engages in developing, manufacturing, and marketing patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services. Its products include FloChec (R) which is used in the office setting to allow healthcare providers to measure arterial blood flow in the extremities and is a useful tool for internists and primary care physicians. Semler Scientific, Inc. is headquartered in Portland, Oregon.
Peers
StrykerBoston ScientificBaxter InternationalBecton, DickinsonAbbottWatersIntegra LifeSciences HoldingsTeleflexCardiovascular Systems3M